| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |